Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: Results of a preliminary study

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 3, 1996, Pages 121-124

  Kurokawa, K ^a   Akizawa, T ^b   Suzuki, M ^c   Akiba, T ^d   Ogata, E ^e   Slatopolsky, E ^f  

^a UNIVERSITY OF TOKYO   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^c Shinrakuen Hospital   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e CANCER INSTITUTE HOSPITAL   (Japan)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

22 oxacalcitriol; Calcitriol; Haemodialysis; Hypercalcaemia; Secondary hyperparathyroidism; Vitamin D pulse therapy

Indexed keywords

22 OXACALCITRIOL; ACID PHOSPHATASE; ALKALINE PHOSPHATASE; PARATHYROID HORMONE;

ADULT; CALCIUM BLOOD LEVEL; CASE REPORT; CONFERENCE PAPER; DRUG EFFECT; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

EID: 0029757288     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp3.121     Document Type: Conference Paper

References (17)

1. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984; 74: 2136-2143
2. Tsukamoto Y, Nomura M, Takahashi Y, Ohkubo M, Kikawada R. The oral 1,25-dihydroxyvitamin D3 in hemodialysis patients with severe secondary hyperparathyroidism. Nephron 1991; 57: 23-28
3. Quarles LD, Yohay DA, Carroll BA et al. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 1994; 45: 1710-1721
4. Fukagawa M, Okazaki R, Takano K et al. Regression of parathyroid hyperplasia by calcitriol pulse therapy in patients on long-term dialysis. N Engl J Med 1990; 323: 421-422
5. Fukagawa M, Kitaoka M, Yi H et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994; 68: 221-228
6. Dunlay R, Rodriguez M, Felsenfeld AJ, Llach F. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int 1989; 36: 1093-1098
7. Kinugasa E, Akizawa T, Koshikawa S. Parathyroid function in end-stage renal failure. J Bone Miner Metab 1993; 11: S9-S14
8. Abe J, Morikawa M, Miyamoto K et al. Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. FEBS Lett 1987; 226: 58-62
9. Brown AJ, Ritter CR, Finch JL et al. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J Clin Invest 1989; 84: 728-732
10. Fukagawa M, Kaname S, Igarashi T, Ogata E, Kurokawa K, Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int 1991; 39: 874-881
11. Kubrusly M, Gagne ER, Urena P et al. Effect of 22-oxacalcitriol on calcium metabolism in rats with severe secondary hyperparathyroidism. Kidney Int 1993; 44: S51-S56
12. Slatopolsky E, Berkoben M, Kelber J, Brown A, Delmez J. Effects of calcitriol and noncalcemic vitamin D analogs on secondary hyperparathyroidism. Kidney Int 1992; 42: S43-S49
13. Finch JL, Brown AJ, Kubodera N. Nishii Y, Slatopolsky E. Differential effect of 1,25(OH)2D3 and 22-oxa-calcitriol on phosphate and calcium metabolism. Kidney Int 1993; 43: 561-566
14. Akizawa T, Fukagawa M, Koshikawa S, Kurokawa K. Recent progress in management of secondary hyperparathyroidism of chronic renal failure. Curr Opin Nephrol Hypertens 1993; 2: 558-565
15. Endo K, Hirata M, Ohkawa H, Kumaki K, Kubodera N, Slatopolsky E. 22-oxa-calcitriol, a noncalcemic analog of 1,25(OH)2D3, is effective in suppressing secondary hyperparathyroidism in uremic rats. J Am Soc Nephrol 1993; 4: 719
16. Takahashi F, Furuichi T, Yorozu K, Abe Y, Kubodera N, Slatopolsky E. Effect of intravenous 22-oxacalcitriol on secondary hyperparathyroidism in dogs with chronic renal failure. J Am Soc Nephrol 1994; 5: 890
17. 3 analogues as new drugs: 22-oxacalcitrol (OCT) and 2-beta-(3-hydroxy-propoxy)calcitrol (ED-71). Abstracts of the XIIth International Congress of Nephrology 1993; 452